Patents by Inventor Hideki Hirose
Hideki Hirose has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20210115048Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: ApplicationFiled: April 26, 2018Publication date: April 22, 2021Inventors: Shuji KITAMURA, Zenichi IKEDA, Minoru IKOMA, Koji WATANABE, Hideki HIROSE, Takafumi YUKAWA, Sachie MORIMOTO, Naoki NISHIZAWA, Taiji ASAMI
-
Patent number: 10919891Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: GrantFiled: April 26, 2018Date of Patent: February 16, 2021Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
-
Patent number: 10875862Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: GrantFiled: April 26, 2018Date of Patent: December 29, 2020Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Shuji Kitamura, Zenichi Ikeda, Sachie Morimoto, Minoru Ikoma, Koji Watanabe, Hideki Hirose, Takafumi Yukawa, Kenjiro Sato
-
Publication number: 20200131174Abstract: The present invention provides a compound or a salt thereof having a calcium-sensing receptor antagonistic activity, and being expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like. The compounds represented by formula (I) or a salt thereof has a calcium-sensing receptor antagonistic activity, and is expected to be useful as an agent for preventing or treating heart failure, pulmonary hypertension, or the like, wherein each symbol is as described in the specification.Type: ApplicationFiled: April 26, 2018Publication date: April 30, 2020Inventors: Shuji KITAMURA, Zenichi IKEDA, Sachie MORIMOTO, Minoru IKOMA, Koji WATANABE, Hideki HIROSE, Takafumi YUKAWA, Kenjiro SATO
-
Patent number: 9751878Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.Type: GrantFiled: April 27, 2016Date of Patent: September 5, 2017Assignee: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
-
Patent number: 9605000Abstract: Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.Type: GrantFiled: March 13, 2014Date of Patent: March 28, 2017Assignee: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Masaki Ogino, Ryo Mizojiri, Takeshi Yamasaki, Hideki Hirose, Nobuyuki Takakura, Tohru Yamashita, Sachie Morimoto, Takashi Nakahata, Asato Kina
-
Publication number: 20160237087Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.Type: ApplicationFiled: April 27, 2016Publication date: August 18, 2016Applicant: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
-
Patent number: 9353108Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.Type: GrantFiled: October 3, 2014Date of Patent: May 31, 2016Assignee: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina
-
Patent number: 9288354Abstract: An image forming apparatus is provided that is capable of returning from a sleep state in response to detection of a user or upon receipt of an input, wherein notification of failure to detect a user is provided if the image forming apparatus returns from a sleep state based on receipt of an input for more than a predetermined number of times.Type: GrantFiled: September 4, 2013Date of Patent: March 15, 2016Assignee: CANON KABUSHIKI KAISHAInventor: Hideki Hirose
-
Publication number: 20160060273Abstract: Provided is a compound represented by the following formula (1) or a salt thereof, which has an SSTR5 antagonistic action: wherein each symbol has the same definition as in the specification.Type: ApplicationFiled: March 13, 2014Publication date: March 3, 2016Applicant: Takeda Pharmaceutical Company LimitedInventors: Shizuo KASAI, Masaki OGINO, Ryo MIZOJIRI, Takeshi YAMASAKI, Hideki HIROSE, Nobuyuki TAKAKURA, Tohru YAMASHITA, Sachie MORIMOTO, Takashi NAKAHATA, Asato KINA
-
Patent number: 9133129Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.Type: GrantFiled: October 23, 2012Date of Patent: September 15, 2015Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Tohru Yamashita, Takuya Fujimoto, Ryo Mizojiri, Kazuko Yonemori, Hideki Hirose, Zenichi Ikeda, Ikuo Fujimori, Kyoko Toyofuku, Tsuneo Yasuma, Nobuyuki Matsunaga
-
Patent number: 9120777Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.Type: GrantFiled: October 28, 2014Date of Patent: September 1, 2015Assignee: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Asato Kina, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Yoichi Nishikawa
-
Publication number: 20150119412Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent the prophylaxis or treatment of diabetes mellitus are provided.Type: ApplicationFiled: October 28, 2014Publication date: April 30, 2015Applicant: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Takashi Nakahata, Asato Kina, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Yoichi Nishikawa
-
Publication number: 20150099777Abstract: A compound having an SSTR5 antagonist action and use of the compound as a medicament are provided. Specifically, a compound represented by the following formula: wherein each symbol is as defined herein, or a salt thereof, a medicament comprising the compound or a salt thereof, and use of the compound or a salt thereof as an agent for the prophylaxis or treatment of diabetes mellitus are provided.Type: ApplicationFiled: October 3, 2014Publication date: April 9, 2015Applicant: Takeda Pharmaceutical Company LimitedInventors: Shizuo Kasai, Hideki Hirose, Takeshi Yamasaki, Tohru Yamashita, Asato Kina, Yoichi Nishikawa
-
Publication number: 20140243310Abstract: The present invention provides a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.Type: ApplicationFiled: October 23, 2012Publication date: August 28, 2014Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITEDInventors: Tohru Yamashita, Takuya Fujimoto, Ryo Mizojiri, Kazuko Yonemori, Hideki Hirose, Zenichi Ikeda, Ikuo Fujimori, Kyoko Toyofuku, Tsuneo Yasuma, Nobuyuki Matsunaga
-
Patent number: 8703758Abstract: The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metabolic syndrome, sarcopenia, cancer and the like, and has superior efficacy. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification.Type: GrantFiled: April 26, 2011Date of Patent: April 22, 2014Assignee: Takeda Pharmaceutical Company LimitedInventors: Tohru Yamashita, Makoto Kamata, Hideki Hirose, Masataka Murakami, Takuya Fujimoto, Zenichi Ikeda, Tsuneo Yasuma, Ikuo Fujimori, Ryo Mizojiri, Tomoya Yukawa
-
Patent number: 8681371Abstract: An image forming apparatus including a formation unit for forming patch images for calibration of an output image, a detection unit disposed on a paper conveyance path and configured to detect the fixed patch images formed on paper by the formation unit, and a correction unit for performing the calibration using the patch images detected by the detection unit is provided. When the formation unit forms the patch images, the formation unit arranges the images on both sides of a medium. On the front surface of the medium, a low-density patch image is formed, and on the back surface of the medium, a high-density patch image is formed. Alternatively, a media on which the patch image is formed is discharged once, and a user turns the medium upside down and feeds the medium again such that the first and second patch image formation positions differ from each other.Type: GrantFiled: June 26, 2012Date of Patent: March 25, 2014Assignee: Canon Kabushiki KaishaInventor: Hideki Hirose
-
Publication number: 20140063528Abstract: An image forming apparatus is provided that is capable of returning from a sleep state in response to detection of a user or upon receipt of an input, wherein notification of failure to detect a user is provided if the image forming apparatus returns from a sleep state based on receipt of an input for more than a predetermined number of times.Type: ApplicationFiled: September 4, 2013Publication date: March 6, 2014Inventor: Hideki Hirose
-
Patent number: 8610912Abstract: An image processing apparatus displays a screen for designating cooperative processing in which the image processing apparatus and at least one other image processing apparatus cooperate based on externally received information, where if an execution instruction for processing to be executed by the image processing apparatus for the cooperative processing is received, the processing is executed. A screen displaying the status of processing in the at least one other image processing apparatus and a screen enabling designation of subsequent processing to be executed by the image processing apparatus are displayed based on the externally received screen information while the at least one other image processing apparatus is executing processing to be executed by the at least one other image processing apparatus for the cooperative processing after the execution of the processing.Type: GrantFiled: November 22, 2011Date of Patent: December 17, 2013Assignee: Canon Kabushiki KaishaInventor: Hideki Hirose
-
Patent number: 8467074Abstract: A method for controlling an apparatus, including a plurality of lockable discharge units configured to discharge a printed product having an image formed thereon based on a received job to any one of the plurality of lockable discharge units, includes managing information about a lockable discharge unit to which the printed product is discharged in association with information about a user, notifying the user to prompt picking up the printed product discharged to the lockable discharge unit based on the managed information, and determining whether a particular user is using the plurality of lockable discharge units based on the managed information, wherein, in a case where the particular user is using the plurality of lockable discharge units, the notification is performed.Type: GrantFiled: May 7, 2010Date of Patent: June 18, 2013Assignee: Canon Kabushiki KaishaInventor: Hideki Hirose